UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2121-2139

2021

Volltextzugriff (PDF)

Current status and future role of brain PET/MRI in clinical and research settings

European journal of nuclear medicine and molecular imaging, 2015-03, Vol.42 (3), p.512-526

2015

Volltextzugriff (PDF)

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2140-2156

2021

Volltextzugriff (PDF)

S.23.04 Multimodal imaging of neuronal function and dysfunction

European neuropsychopharmacology, 2013-10, Vol.23, p.S145-S145

Drzezga, A

2013

Volltextzugriff (PDF)

Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2097-2109

2021

Volltextzugriff (PDF)

Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18

Annals of oncology, 2018-09, Vol.29 (9), p.1926-1931

2018

Volltextzugriff (PDF)

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2070-2085

2021

Volltextzugriff (PDF)

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease

Neurology, 2009-04, Vol.72 (17), p.1487-1494

2009

Volltextzugriff (PDF)

Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study

Neurobiology of aging, 2007-01, Vol.28 (1), p.42-50

2007

Volltextzugriff (PDF)

Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment

European journal of nuclear medicine and molecular imaging, 2022-11, Vol.49 (13), p.4478-4489

2022

Volltextzugriff (PDF)

Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study

Neurobiology of aging, 2004-09, Vol.25 (8), p.1051-1056

2004

Volltextzugriff (PDF)

Dominance for Vestibular Cortical Function in the Non-dominant Hemisphere

Cerebral cortex (New York, N.Y. 1991), 2003-09, Vol.13 (9), p.994-1007

2003

Volltextzugriff (PDF)

Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study

NeuroImage clinical, 2015-01, Vol.7 (C), p.34-42

2015

Volltextzugriff (PDF)

The effectiveness of wastewater treatment in nuclear medicine: Performance data and radioecological considerations

Journal of environmental radioactivity, 2017-01, Vol.166 (Pt 1), p.202-207

2017

Volltextzugriff (PDF)

Combined Early and Late [68Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels

Molecular imaging and biology, 2019-06, Vol.21 (3), p.558-566

2019

Volltextzugriff (PDF)

The importance of molecular imaging (PET) in the diagnostics of dementia

Nervenarzt, 2018-07, Vol.89 (7), p.843

2018

Volltextzugriff (PDF)

Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here: Summary Report of the 4th International Workshop on PET/MR Imaging; February 23–27, 2015, Tübingen, Germany

Molecular Imaging and Biology : MIB, 2015-10, Vol.17 (5), p.595-608

2015

Volltextzugriff (PDF)

Feasibility of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET for treatment monitoring of brain metastases in lung cancer patients

Annals of oncology, 2019-04, Vol.30, p.ii64-ii65

2019

Volltextzugriff (PDF)

European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus

European journal of neurology, 2018-10, Vol.25 (10), p.1201-1217

2018

Volltextzugriff (PDF)

European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus

European journal of neurology, 2018-10, Vol.25 (10), p.1201-1217

2018

Volltextzugriff (PDF)

Exhalation of 131I after radioiodine therapy: Dosimetric considerations based on measurements in exhaled air

Journal of environmental radioactivity, 2017-01, Vol.166, p.162-165

2017

Volltextzugriff (PDF)

Schooling mediates brain reserve in Alzheimer’s disease: findings of fluoro-deoxy-glucose-positron emission tomography

Journal of neurology, neurosurgery and psychiatry, 2006-09, Vol.77 (9), p.1060-1063

2006

Volltextzugriff (PDF)

Cerebral glucose metabolism in patients with AD and different APOE genotypes

Neurology, 2005-01, Vol.64 (1), p.102-107

2005

Volltextzugriff (PDF)

Retention efficacy and release of radioiodine in fume hoods

Journal of environmental radioactivity, 2017-01, Vol.166 (Pt 1), p.175-180

2017

Volltextzugriff (PDF)

The patient as a radioactive source: an intercomparison of survey meters for measurements in nuclear medicine

Radiation protection dosimetry, 2014-11, Vol.162 (1-2), p.101-104

2014

Volltextzugriff (PDF)

1 – 25 von 702

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(662)
Mit Volltextzugriff
(592)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(329)
Life Sciences & Biomedicine
(312)
Humans
(266)
Male
(187)
Female
(161)
Positron Emission Tomography
(142)
Neurosciences & Neurology
(141)
Radiology, Nuclear Medicine & Medical Imaging
(135)
Middle Aged
(131)
Aged
(129)
Alzheimer's Disease
(129)
Neurology
(119)
Neurosciences
(110)
Positron-Emission Tomography
(105)
Nuclear Medicine
(93)
Fluorodeoxyglucose F18
(87)
Medicine
(85)
Tomography
(83)
Medicine & Public Health
(81)
Imaging
(74)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

Current status and future role of brain PET/MRI in clinical and research settings

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

S.23.04 Multimodal imaging of neuronal function and dysfunction

Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework

Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease

Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study

Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment

Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study

Dominance for Vestibular Cortical Function in the Non-dominant Hemisphere

Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study

The effectiveness of wastewater treatment in nuclear medicine: Performance data and radioecological considerations

Combined Early and Late [68Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels

The importance of molecular imaging (PET) in the diagnostics of dementia

Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here: Summary Report of the 4th International Workshop on PET/MR Imaging; February 23–27, 2015, Tübingen, Germany

Feasibility of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET for treatment monitoring of brain metastases in lung cancer patients

European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus

European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus

Exhalation of 131I after radioiodine therapy: Dosimetric considerations based on measurements in exhaled air

Schooling mediates brain reserve in Alzheimer’s disease: findings of fluoro-deoxy-glucose-positron emission tomography

Cerebral glucose metabolism in patients with AD and different APOE genotypes

Retention efficacy and release of radioiodine in fume hoods

The patient as a radioactive source: an intercomparison of survey meters for measurements in nuclear medicine

Suchergebnisse filtern